MedPath

长春天诚药业有限公司

Ownership
-
Established
1992-08-25
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

58

NMPA:58

Drug Approvals

Compound Amino Acid Injection(15AA)

Product Name
复方氨基酸注射液(15AA)
Approval Number
国药准字H22022821
Approval Date
Feb 8, 2024
NMPA

Compound Amino Acid Injection(15AA)

Product Name
复方氨基酸注射液(15AA)
Approval Number
国药准字H22023367
Approval Date
Feb 8, 2024
NMPA

Compound Amino Acid Injection(15AA)

Product Name
复方氨基酸注射液(15AA)
Approval Number
国药准字H22023366
Approval Date
Feb 8, 2024
NMPA

Compound Amino Acid Injection(6AA)

Product Name
复方氨基酸注射液(6AA)
Approval Number
国药准字H22026345
Approval Date
Feb 8, 2024
NMPA

Propyl Gallate and Glucose Injection

Product Name
倍治
Approval Number
国药准字H20051753
Approval Date
Feb 8, 2024
NMPA

Compound Amino Acid Injection(18AA)

Product Name
复方氨基酸注射液(18AA)
Approval Number
国药准字H22023368
Approval Date
Feb 8, 2024
NMPA

Compound Amino Acid Injection(18AA)

Product Name
复方氨基酸注射液(18AA)
Approval Number
国药准字H22025620
Approval Date
Jan 18, 2024
NMPA

Thymopolypeptides and Sodium Chloride Injection

Product Name
新状泰
Approval Number
国药准字H20034180
Approval Date
Jan 18, 2024
NMPA

Compound Amino Acid Injection(18AA)

Product Name
复方氨基酸注射液(18AA)
Approval Number
国药准字H22022822
Approval Date
Jan 18, 2024
NMPA

Compound Sodium Chloride Injection

Product Name
复方氯化钠注射液
Approval Number
国药准字H22022760
Approval Date
Jan 12, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.